Natural history of multiple system atrophy in the USA: a prospective cohort study - Wikidata - wikimedia - TriplyDB

Natural history of multiple system atrophy in the USA: a prospective cohort study

Natural history of multiple system atrophy in the USA: a prospective cohort study

http://www.wikidata.org/entity/Q30279265

about

Review: Multiple system atrophy: emerging targets for interventional therapies Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders Multiple system atrophy: clinicopathological characteristics in Japanese patients.Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.Prediction of orthostatic hypotension in multiple system atrophy and Parkinson disease Clinical features and autonomic testing predict survival in multiple system atrophy.α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.Atypical Parkinsonian syndromes: a general neurologist's perspective.Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.Genetic susceptibility variants in parkinsonism.Toward disease modification in multiple system atrophy: Pitfalls, bottlenecks, and possible remedies.Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.Multiple system atrophy: insights into a rare and debilitating movement disorder.The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis.Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.MAPT haplotype diversity in multiple system atrophy Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.First symptoms in multiple system atrophy.Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.Causes of Death in Chinese Patients with Multiple System Atrophy.Diagnosis of multiple system atrophy.Alpha-synuclein levels in patients with multiple system atrophy: a meta-analysis.Extensive Delayed Brain Atrophy after Resuscitation in a Patient with Multiple System Atrophy.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.Supine hypertension in Parkinson's disease and multiple system atrophy.Autonomic failure and reduced survival in multiple system atrophy.Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells.Functional Variant rs3135500 in NOD2 Increases the Risk of Multiple System Atrophy in a Chinese Population.Possible multiple system atrophy with predominant parkinsonism in a patient with chronic schizophrenia: a case report.Clinics in diagnostic imaging (191). Multiple system atrophy-cerebellar type (MSA-C)Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis

P2860

Q26770919-44F5F1FC-BB52-4BB3-9973-55FE361133B3 Q26779001-EC484E47-AB7A-45A5-95C9-572DE3DCDE79 Q30234494-64CE3B5F-DFF1-443A-8125-7D386D86B4A5 Q33776552-41CEF84E-1688-476D-9E89-E67D987CD3A7 Q33805560-BEBB0E71-8713-48AB-ABB2-F3CC5EF8C740 Q36574394-13AC9D59-FBC6-4512-ADAA-4B5B8078E8FB Q36824638-A2C4C0CF-7FEE-49BC-BE04-3688A418845E Q37017296-E38F9EC5-F81E-4215-9A01-B72985A0588D Q38372272-789448E4-C3A5-404C-A047-ECF10514F033 Q38373533-7BA71791-EB3F-4C77-86D3-50861449FCE2 Q38594414-0125DE0B-3073-432F-AC7C-74F7F31C2887 Q38712697-A72F76E4-4655-41DB-804E-C65D033B1A74 Q38896237-7228B82E-5F9A-4F9B-8A78-8815884296F9 Q39183459-AA5F32BB-E888-4B5A-B5CB-5A80C4B9DD60 Q39360892-99A3AA75-C1BB-4527-9920-9BF5E1F40B42 Q39438327-B3CA8B38-E19B-4DF0-BA74-0FB46F12DC01 Q40063193-41328E4B-3080-4E01-B30E-CF0534C8BF63 Q40989131-CC923548-5CEE-4EA1-A8AD-6520A583DE06 Q41046889-BBBD7877-31BC-4C6D-A60D-3768980F40F8 Q44457611-FA6733A4-6AB8-4A1D-99E0-6DED4028013D Q45998422-34923F0D-A21C-4D30-8806-E43F2088519A Q47192877-1B66B901-9EC1-43B9-9965-A967ECB94D5D Q47615924-888DD23A-7494-4689-9234-3FDCA24C912F Q47639031-3E86704D-4A31-4DAE-AD48-3C2F69F1F7C9 Q47665262-C48659D8-9F0D-4094-8EC0-149E524F58C3 Q47754301-E2AA31DE-73CD-4B67-955D-847695FBCCBB Q47833158-4F30AC41-A6A9-46E2-962B-977A1CC637FF Q49562668-0B624176-8F35-4FE9-9319-6BC6D5743196 Q50544796-0BD3A357-8DA2-4DDB-88CF-78E75B082A02 Q52146543-22C956CF-6C54-4DFA-8C15-789595F2EC0C Q52147948-346C9065-84C9-4EE0-983C-CEFB6C8A123A Q52672547-1E7A75A8-E000-472D-94DA-1C5A7014AF0C Q52675408-A4EF55D5-1EFF-49FD-A1B6-B2DC126D197B Q54978989-80EE066F-AC43-4800-BDE2-E668EEA0C6B8 Q55341701-2633A872-54C9-43E8-8293-BA40C4E967F7 Q58602545-9996F139-E3AB-4BC0-9796-2AB46981A1B6 Q58791873-B0E9AECC-2927-4A4A-82CC-BD591CE2AF06

P2860

Natural history of multiple system atrophy in the USA: a prospective cohort study

http://www.wikidata.org/entity/Q30279265

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Natural history of multiple system atrophy in the USA: a prospective cohort study

@ast

Natural history of multiple system atrophy in the USA: a prospective cohort study

@en

type

label

Natural history of multiple system atrophy in the USA: a prospective cohort study

@ast

Natural history of multiple system atrophy in the USA: a prospective cohort study

@en

prefLabel

Natural history of multiple system atrophy in the USA: a prospective cohort study

@ast

Natural history of multiple system atrophy in the USA: a prospective cohort study

@en

P1433

Q30279265-F7844C88-FB1A-4E09-8EB7-9A62DCF7B31A

P1476

Q30279265-1044D9B9-233D-4A09-A2D8-16878B14F23E

P2093

Q30279265-0E925FA5-6303-4395-984D-B51233A6AAA2

Q30279265-16B42519-B4AA-4688-A6D4-AE9F2A05FCD8

Q30279265-3F22A268-186F-4A91-864A-45C2D01E6AB3

Q30279265-46516C01-30D4-4408-8EE4-2B9A661535A1

Q30279265-525BF9F1-36FD-450E-9E0E-21783CDADBE0

Q30279265-6C8F6513-6636-48EC-899E-07B4E055C868

Q30279265-99139D78-1EED-4F6F-B8CE-D234DBFDDF4D

Q30279265-9F61DCC3-040C-4846-B5B3-4017E6574A06

Q30279265-AEC82E47-61B2-4707-B0A3-2565B85DA292

Q30279265-D81143C1-ABE4-4C4E-99E2-BE82A52B6DEE

P2860

Q30279265-053976A5-28F4-4727-BCFD-D939B6F2241E

Q30279265-0A87DEB3-ECB3-4BE6-B00F-832143F8F935

Q30279265-2A132BBD-C521-43AC-9B30-0CA918885CF1

Q30279265-2EFB6759-9E5F-4984-824A-4D97564C9DEB

Q30279265-43AB29FC-0F90-41C1-88C7-668937C3AAF3

Q30279265-51563A18-0908-41D7-BEA4-8FC0A3825024

Q30279265-5323A355-B265-4AEE-A0A6-FDEF7FE6A271

Q30279265-74046A63-33D6-41BC-AC8E-08E1027D1B85

Q30279265-7B7D9F73-8C8F-4045-AC3E-AB8BC480D050

Q30279265-864659C9-66DC-47F4-BFE6-505D68E6F3C8

P304

Q30279265-3C162BEC-642D-45E2-ABD2-AFDD3079BD66

P31

Q30279265-30552BAA-BEF1-4B29-B028-087DEF252906

P356

Q30279265-AAA53A5F-6F4C-476D-9E63-BBCA03D2D98E

P433

Q30279265-505231D2-F812-465F-8717-CFFE932581F9

P478

Q30279265-A6A6A93C-AF5E-4F65-9226-7AAC68A38209

P50

Q30279265-5565536A-9636-4F02-8B47-E0EEF11B18BE

Q30279265-6494B256-9C7C-45A8-BC7B-8D956880ABCF

P577

Q30279265-173D8BC8-811B-4FF0-8B77-1E48EEDEE7A4

P698

Q30279265-95492D77-E707-4A59-B17A-20904E68EA75

P932

Q30279265-1B4D187C-0A47-4FAA-8D62-CF6419170F24

P356

S1474-4422(15)00058-7

P1433

Lancet Neurology

P1476

Natural history of multiple system atrophy in the USA: a prospective cohort study

@en

P2093

Brad Racette

http://www.w3.org/2001/XMLSchema#string

Clifford W Shults

http://www.w3.org/2001/XMLSchema#string

David M Sletten

http://www.w3.org/2001/XMLSchema#string

Frederick J Marshall

http://www.w3.org/2001/XMLSchema#string

Frederick Wooten

http://www.w3.org/2001/XMLSchema#string

Jay Mandrekar

http://www.w3.org/2001/XMLSchema#string

Matthew B Stern

http://www.w3.org/2001/XMLSchema#string

Paola Sandroni

http://www.w3.org/2001/XMLSchema#string

Peter Novak

http://www.w3.org/2001/XMLSchema#string

Phillip A Low

http://www.w3.org/2001/XMLSchema#string

P2860

Second consensus statement on the diagnosis of multiple system atrophy

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

Multiple system atrophy: a clinical and neuropathological perspective

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.

Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.

Towards translational therapies for multiple system atrophy

Multiple system atrophy: prognostic indicators of survival.

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

P304

710-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(15)00058-7

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Jankovic

Caroline M Tanner

P577

2015-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26025783

http://www.w3.org/2001/XMLSchema#string

P932

4472464

http://www.w3.org/2001/XMLSchema#string